The Capacity of HIV Care Facilities to Implement Strategies Recommended by the Ending the HIV Epidemic Initiative: The Medical Monitoring Project Facility Survey.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
received:
07
04
2023
accepted:
15
08
2023
pmc-release:
01
12
2024
medline:
30
10
2023
pubmed:
29
8
2023
entrez:
29
8
2023
Statut:
ppublish
Résumé
Data are needed to assess the capacity of HIV care facilities to implement recommended Ending the HIV Epidemic activities. US HIV care facilities. We analyzed 2021 survey data from 514 facilities that were recruited from a census of facilities providing care to a national probability sample of US adults with HIV. We present weighted estimates of facility characteristics, services, and policies and estimates of the proportion of all US HIV patients attending these facilities. Among HIV care facilities, 37% were private practices, 72% were in areas with population >1 million, and 21% had more than 1000 HIV patients. Most provided preexposure prophylaxis (83%) and postexposure prophylaxis (84%). More than 67% of facilities provided HIV-specific stigma or discrimination training for all staff (covering 70% of patients) and 66% provided training on cultural competency (covering 74% of patients). A majority of patients attended facilities that provided on-site access to HIV/sexually transmitted infection (STI) transmission risk reduction counseling (89%); fewer had on-site access to treatment for substance use disorders (35%). We found low provision of on-site assistance with food banks or meal delivery (14%) and housing (33%). Approximately 71% of facilities reported using data to systematically monitor patient retention in care. On-site access to adherence tools was available at 58% of facilities; 29% reported notifying patients of missed prescription pickups. Results indicate some strengths that support Ending the HIV Epidemic-recommended strategies among HIV care facilities, such as high availability of preexposure prophylaxis/postexposure prophylaxis, as well as areas for improvement, such as provision of staff antistigma trainings and adherence supports.
Sections du résumé
BACKGROUND
Data are needed to assess the capacity of HIV care facilities to implement recommended Ending the HIV Epidemic activities.
SETTING
US HIV care facilities.
METHODS
We analyzed 2021 survey data from 514 facilities that were recruited from a census of facilities providing care to a national probability sample of US adults with HIV. We present weighted estimates of facility characteristics, services, and policies and estimates of the proportion of all US HIV patients attending these facilities.
RESULTS
Among HIV care facilities, 37% were private practices, 72% were in areas with population >1 million, and 21% had more than 1000 HIV patients. Most provided preexposure prophylaxis (83%) and postexposure prophylaxis (84%). More than 67% of facilities provided HIV-specific stigma or discrimination training for all staff (covering 70% of patients) and 66% provided training on cultural competency (covering 74% of patients). A majority of patients attended facilities that provided on-site access to HIV/sexually transmitted infection (STI) transmission risk reduction counseling (89%); fewer had on-site access to treatment for substance use disorders (35%). We found low provision of on-site assistance with food banks or meal delivery (14%) and housing (33%). Approximately 71% of facilities reported using data to systematically monitor patient retention in care. On-site access to adherence tools was available at 58% of facilities; 29% reported notifying patients of missed prescription pickups.
CONCLUSION
Results indicate some strengths that support Ending the HIV Epidemic-recommended strategies among HIV care facilities, such as high availability of preexposure prophylaxis/postexposure prophylaxis, as well as areas for improvement, such as provision of staff antistigma trainings and adherence supports.
Identifiants
pubmed: 37643411
doi: 10.1097/QAI.0000000000003290
pii: 00126334-202312010-00002
pmc: PMC10615730
mid: NIHMS1925890
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
290-300Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
JAMA. 2019 Jun 11;321(22):2214-2230
pubmed: 31184746
Open Forum Infect Dis. 2018 May 02;5(6):ofy097
pubmed: 29977957
AIDS Behav. 2016 Jan;20(1):115-25
pubmed: 26650383
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640
pubmed: 24242258
Behav Med. 2014;40(2):43-52
pubmed: 24274175
Clin Infect Dis. 2016 Oct 1;63(7):966-975
pubmed: 27358352
AIDS Patient Care STDS. 2018 Feb;32(2):39-41
pubmed: 29432044
Open Forum Infect Dis. 2018 Jun 28;5(6):ofy104
pubmed: 29992172
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S47-S54
pubmed: 34686290
AIDS Behav. 2016 Jan;20(1):29-50
pubmed: 26303196
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
Health Psychol. 2003 Sep;22(5):533-40
pubmed: 14570537
Patient Prefer Adherence. 2017 Feb 28;11:373-379
pubmed: 28280310
Soc Sci Med. 2019 Jul;232:86-93
pubmed: 31075752
AIDS Patient Care STDS. 2018 Oct;32(10):418-424
pubmed: 30277814
J Racial Ethn Health Disparities. 2020 Apr;7(2):383-391
pubmed: 31808137
Prev Chronic Dis. 2021 Aug 12;18:E78
pubmed: 34387188
J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):282-289
pubmed: 34651603
MMWR Morb Mortal Wkly Rep. 2021 Dec 03;70(48):1669-1675
pubmed: 34855721
JMIR Res Protoc. 2019 Nov 18;8(11):e15453
pubmed: 31738178
AIDS Educ Prev. 2012 Oct;24(5):408-21
pubmed: 23016502
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
AIDS Behav. 2014 May;18(5):972-96
pubmed: 24531769
AIDS Behav. 2018 Feb;22(2):522-530
pubmed: 29214408